YSB Inc.

药师帮股份有限公司

09885.HK

Operates a digital platform for pharmaceutical circulation outside hospitals in China, connecting pharmaceutical companies, distributors and vendors with pharmacies and primary healthcare institutions. Recorded RMB37.8 billion GMV in 2022, a 21.0% share of China's digital outside-of-hospital pharmaceutical market.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Overlapping customers and suppliers
• Single product, business line or region
• Particular sales arrangements
• Business changes and acquisitions
• Seasonality and cyclicality
• Losses and path to profitability
• Net current liabilities or net liabilities
• Negative operating cash flow
• Working capital: receivables, prepayments and cash cycle
• Inventory level and ageing
• Goodwill, intangibles and asset impairment
• Preferred shares and fair-value liabilities
• Investments and fair-value assets
• Adverse change after the track record
• Non-IFRS measures and adjustments
• Related-party transactions and balances
• Contractual arrangements (VIE)